SCHEMBL14083936

SCHEMBL14083936

COc1ccc(NC(=O)c2ccc(-c3ncccc3Cl)cn2)cc1Cl

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 3/20 0.66
▸ LMNA P02545 1/20 0.55
▸ TP53 P04637 1/20 0.55
▸ HDAC6 Q9UBN7 1/20 0.54
▸ SMN1; SMN2 Q16637 7/20 0.53
▸ NPC1 O15118 6/20 0.53
▸ RAB9A P51151 6/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ MALT1 Q9UDY8 3/20 0.51
▸ MAPT P10636 4/20 0.50
▸ TRPV1 Q8NER1 2/20 0.50
▸ USP2 O75604 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ GLA P06280 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ NFKB1 P19838 1/20 0.48
▸ NFKB2 Q00653 1/20 0.48
▸ RELA Q04206 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083998 0.94 KDM4E (0.62) GRM4LMNAHDAC6SMN1; SMN2NPC1
SCHEMBL14083996 0.92 GRM4 (0.55) GRM4LMNATP53HDAC6SMN1; SMN2
SCHEMBL14084038 0.88 TRPV1 (0.55) GRM4LMNAHDAC6SMN1; SMN2NPC1
SCHEMBL14083480 0.88 GRM4 (0.67) GRM4LMNATP53HDAC6SMN1; SMN2
SCHEMBL14084015 0.87 SMN1; SMN2 (0.62) GRM4LMNATP53HDAC6SMN1; SMN2
SCHEMBL14083905 0.85 RAB9A (0.60) LMNASMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL14083930 0.85 GRM4 (0.62) GRM4LMNATP53SMN1; SMN2NPC1
SCHEMBL14083963 0.83 POLB (0.53) LMNASMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL14083353 0.83 GRM4 (0.58) GRM4LMNATP53HDAC6SMN1; SMN2
SCHEMBL14083594 0.83 NPC1 (0.63) GRM4LMNATP53HDAC6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 GRM4 362/4885LMNA 2619/4885TP53 4256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback